Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Frideriki Poutoglidou"'
Autor:
Frideriki Poutoglidou, Marios Stavrakas, Nikolaos Tsetsos, Alexandros Poutoglidis, Aikaterini Tsentemeidou, Georgios Fyrmpas, Petros D. Karkos
Publikováno v:
Voices in Bioethics, Vol 8 (2022)
Photo by Agni B on Unsplash ABSTRACT The number of scientific articles published per year has been steadily increasing; so have the instances of misconduct in medical research. While increasing scientific knowledge is beneficial, it is imperative
Externí odkaz:
https://doaj.org/article/bdd782504fe7445d82d45c69af3dfd82
Publikováno v:
Expert Review of Respiratory Medicine. 15:979-983
Introduction: The Coronavirus disease 2019 (COVID-19) poses novel challenges in the healthcare systems around the world. Concern about the role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and, in particular, ibuprofen has led to significant spe
Autor:
Athanasios Saitis, Frideriki Poutoglidou, Dimitrios Kouvelas, Maria Eleni Manthou, Chryssa Pourzitaki, Efthimios Samoladas, Foteini Malliou
Publikováno v:
Inflammopharmacology. 29:661-672
Reduced Bone Mineral Density (BMD) and tendon abnormalities, such as tenosynovitis and enthesitis, are prevalent comorbidities in patients with rheumatoid arthritis (RA). The aim of the present study was to investigate the effect of chronic treatment
Publikováno v:
SN Comprehensive Clinical Medicine. 3:754-758
Sprengel’s deformity is a congenital anomaly characterized by a hypoplastic and elevated scapula that results in cosmetic and functional impairment. In this study, we report the results of 3 severe cases of bilateral Sprengel’s deformity with ass
Autor:
Frideriki Poutoglidou, Chryssa Pourzitaki, Maria Eleni Manthou, Efthimios Samoladas, Athanasios Saitis, Foteini Malliou, Dimitrios Kouvelas
Publikováno v:
Connective tissue research. 63(6)
Reduced Bone Mineral Density (BMD) is a prevalent comorbidity in Juvenile Idiopathic Arthritis (JIA). Enthesitis and other tendon abnormalities, such as tenosynovitis, tendinitis and tendon ruptures are, also, common extra-articular manifestations of
Publikováno v:
SN Comprehensive Clinical Medicine. 2:1922-1925
Chondrolysis of the hip is a rare condition characterized by progressive destruction of the articular cartilage of the femoral head and the acetabulum. The clinical outcome varies from complete recovery to severe ankylosis of the hip joint. The etiol
Autor:
Chryssa Pourzitaki, Dimitrios Kouvelas, Frideriki Poutoglidou, Ioannis Dardalas, Vasilios K. Kimiskidis
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 19:220-226
Background: Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive brain stimulation technique that is being actively explored as a potential therapeutic modality in various neuropsychiatric disorders, such as depression, neuropathic p
Autor:
Stefanos Chatzis, Frideriki Poutoglidou, Alexandros Poutoglidis, Damianos Sotiropoulos, Christos Savopoulos, Angeliki Xagorari, Stergiani Keramari, Katerina Chlichlia, Georgia Kaiafa
Publikováno v:
Cureus
Adenoviral infections in immunocompromised individuals may be life-threatening conditions. The aim of this review is to document all the reported cases of adenoviral infection is patients having undergone bone marrow transplantation (BMT). A comprehe
Autor:
Michael Keramaris, Stergiani Keramari, Frideriki Poutoglidou, Alexandros Poutoglidis, Georgia Kaiafa
Publikováno v:
Cureus
Propafenone is an antiarrhythmic agent for the management of ventricular and supraventricular tachycardia and atrial fibrillation. Propafenone poisoning is rare but may be life-threatening due to drug-induced arrhythmias. Electrocardiographic changes
Autor:
Chryssa Pourzitaki, Dimitrios Kouvelas, Athanasios Saitis, Spyridon Panagiotopoulos, Maria Eleni Manthou, Foteini Malliou, Ioannis Tsimoulas, Frideriki Poutoglidou
Publikováno v:
Pharmacological reports : PR. 74(1)
Circulating cytokines have been proposed to be implicated in the development of mood disorders and cognitive impairment. This study aims to examine the effect of chronic treatment with infliximab, a tumor necrosis factor-alpha (TNF-alpha) inhibitor,